Company intelligence / Profile preview

NuTech Medical

Birmingham, Alabama, United Statesnutechspine.com ↗

Ownership: Private
Development stage: Commercial

Overview

NuTech Medical developed and commercialized a range of biologic and device products for orthopedic, spinal, and sports medicine applications. Its amniotic stem-cell-based product line was acquired by Organogenesis in March 2017. The company held multiple patents related to placental membrane preparations for cartilage regeneration and spinal disc repair.

Therapeutic areas: OtherRheumatologyNeurology
Modalities: BiologicDeviceSmall molecule
Industry: Biotech

Drug pipeline

4 assets

Affinity

Commercial

Indications: Wound healing, Surgical applications

3 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on NuTech Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NuTech Medical.

Explore the full profile